How much funding has Ability Pharmaceuticals raised?

Ability Pharmaceuticals has raised $8.6M in total funding, most recently a growth equity round.

Who are Ability Pharmaceuticals's investors?

Ability Pharmaceuticals's investors include Inveready, European Innovation Council Fund.

When was Ability Pharmaceuticals founded?

Ability Pharmaceuticals was founded in 2012.

Where is Ability Pharmaceuticals headquartered?

Ability Pharmaceuticals is headquartered in Cerdanyola del Vallès.

What industry is Ability Pharmaceuticals in?

Ability Pharmaceuticals operates in Biotech, Healthcare.

How many employees does Ability Pharmaceuticals have?

Ability Pharmaceuticals has 11-50 employees.

Ability Pharmaceuticals

Cerdanyola del Vallès · Founded 2012 · $8.6M raised

Biotech

Healthcare

Headquarters: Cerdanyola del Vallès
Employees: 11–50
Founded: 2012
Business Model: B2B

Website: abilitypharma.com
Total Funding: $8.6M
Last Round: $7.6M Growth EquityJul 2024
Rounds: 2

About

Ability Pharmaceuticals (AbilityPharma) is a clinical-stage biopharmaceutical company headquartered in Cerdanyola del Vallès (Barcelona), Catalonia, Spain, focused on developing first-in-class cancer therapies through autophagy induction. The company's lead compound, ABTL0812 (Ibrilatazar), is currently in a Phase 2b double-blind placebo-controlled clinical trial in 140 patients with metastatic pancreatic cancer across the USA, Spain, France, and Israel, and has shown positive results in Phase 2a trials for endometrial and lung cancer. AbilityPharma investigates drugs that selectively induce cytotoxic autophagy in cancer cells, targeting major oncological unmet needs with a novel mechanism of action.

Summary

Ability Pharmaceuticals is a Biotech company based in Cerdanyola del Vallès, founded in 2012. It has raised $8.6M in total across 2 rounds, most recently a $7.6M Growth Equity round in Jul 2024. Investors include Inveready and European Innovation Council Fund.